a report you can trace to its sources.

Below is part of a real report: a University of Pennsylvania disclosure from 2011, scored only on public records dated before that day. Every number links to the register it came from.

Invention report, sample

cancer t-cell therapy

University of Pennsylvania, US patent 8,916,381, disclosed 2011-12-09

Deal chance5.7%chance of a licence or startup within about three years, range 5.1% to 6.4%
Among earlier disclosures59thpercentile of 48,991 earlier university records, about the average
RecommendationReviewdemonstration rule, not set by any office

what the score rests on

Each fact is ranked among earlier disclosures that have the same fact. A percentile of 86 means 86% of comparable earlier records had fewer. The four measures below have weights learnt from what happened to those earlier records.

IP defensibilitythe patent itself0.49
  • Claims2886th percentileUSPTO
  • Earlier patents it cites7096th percentileUSPTO
  • Independent claims117th percentileUSPTO
Inventor alignmentthe team0.95
  • Earlier patents by the inventors4995th percentileUSPTO
Translational fundingthe money behind it0.82
  • NIH funding$6.6 million66th percentileNIH RePORTER
  • Separate grants498th percentileNIH RePORTER
Market signalothers in the space0.95
  • Different patent owners in the field795th percentileUSPTO

dealbreaker checks

  • ClearOwnershipThe university is the owner of record, with a clean assignment chain.
  • ClearLegal challengesNo challenge filed at the patent office.
  • ClearPatent lifeAbout 20 years of patent life left at the disclosure date.
  • Not checkedBlocking patentsClaims not yet compared with patents in force.

what happened later

Shown for context and never used in the score, because it is dated after the disclosure. The patent was licensed to Novartis, and the therapy became the first CAR T-cell treatment approved by the FDA, in August 2017.

the same report on a weaker case

Cancer T-cell therapyUniversity of Pennsylvania, 20115.7%Review

A widely cited paper, an experienced team and steady funding.

Porous tissue materialUniversity of Michigan, 20042.9%Hold

No linked papers, fewer earlier patents from the team (5, 59th percentile) and no trials. The 35th percentile, half the average.

Sample from a real run on public records. The recommendation rule is a demonstration. Full reports, with all nine measures, every fact and a PDF, are in the console for signed-in users.

What a report holds.

The answer

One deal chance

The chance of a licence or startup, where it sits among earlier disclosures, and a recommendation with the rule that produced it.

The reasons

Nine measures

Each measure with its parts, each part with the facts behind it, and each fact with the record and the date it was read.

The limits

What is missing

Facts that could not be found are listed, never filled in. Records dated after the disclosure are shown as context only, never scored.